Hostname: page-component-78c5997874-94fs2 Total loading time: 0 Render date: 2024-11-19T10:25:52.861Z Has data issue: false hasContentIssue false
  • English
  • Français

Lamotrigine Combined with Divalproex or Lithium for Bipolar Disorder: A Case Series

Published online by Cambridge University Press:  07 November 2014

James R. Redmond ,
Katrina L. Jamison  and
Charles L. Bowden
Get access Rights & Permissions [Opens in a new window]

Abstract

Objective

To assess the efficacy of lamotrigine combined with either divalproex or lithium for the treatment of bipolar disorder.

Introduction

Lithium and divalproex seem to be predominantly effective for manic and mixed symptoms of bipolar disorder, whereas lamotrigine may be more effective for bipolar depression than for mania. Combination therapy may provide more efficacious treatment for many patients with bipolar disorder.

Methods

Data from charts of adult outpatients with bipolar disorder treated with lamotrigine plus divalproex or lithium during a 3-year period were retrospectively analyzed. The Clinical Global Impressions for Bipolar Disorder scale was used to assess severity of illness at baseline (adjunct-therapy initiation) and improvement after 3 months of treatment. The safety and tolerability of the medication combinations were assessed.

Results

After 3 months of treatment, 26 of 39 patients (67%) receiving lamotrigine plus divalproex had a depression rating of 1 (very much improved) or 2 (much improved) compared with seven of 16 (44%) taking lamotrigine plus lithium. The mania rating was 1 or 2 for 13 of 39 (39%) patients treated with lamotrigine plus divalproex and 7 of 16 (44%) patients receiving lamotrigine plus lithium. For overall illness severity, 26 of 39 (67%) patients given lamotrigine plus divalproex had scores of 1 or 2 compared with 10 of 16 (62%) patients taking lamotrigine plus lithium. Five of 39 patients (13%) taking lamotrigine plus divalproex and 5 of 16 (31%) receiving lamotrigine plus lithium discontinued at least one part of the combination in <3 months due to adverse events.

Conclusion

Combination therapy with lamotrigine plus divalproex or lithium may be a valuable option for managing symptoms of bipolar disorder. The combinations were generally well tolerated and apparently effective in improving depression as well as mania.The percentage of patients showing improvement in depression was somewhat larger. Tolerability was somewhat better for lamotrigine plus divalproex in combination than for lamotrigine plus lithium. Differences in tolerability are consistent with studies indicating poorer tolerability of lithium compared with divalproex.

Type
Original Research
Information
CNS Spectrums , Volume 11 , Issue 12 , December 2006 , pp. 915 - 918
Copyright
Copyright © Cambridge University Press 2006

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

1. American Psychiatric Association. Practice guideline for the treatment of patients with bipolar disorder (revision). Am J Psychiatry. 2002;159(suppl):1–50.Google Scholar
2. Bowden, CL, Mitchell, P, Suppes, T. Lamotrigine in the treatment of bipolar depression. Eur Neuropsychopharmacol. 1999;9(suppl 4):S1113–S1117.Google Scholar
3. Calabrese, JR, Bowden, CL, Sachs, GS, Ascher, JA, Monaghan, E, Rudd, GD. A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. J Clin Psychiatry. 1999;60:79–88.Google Scholar
4. Goodwin, GM, Bowden, CL, Calabrese, JR, et al. A pooled analysis of 2 placebo controlled 18-month trials of lamotrigine and lithium maintenance in bipolar disorder. J Clin Psychiatry. 2004;65:432–441.Google Scholar
5. Calabrese, JR, Suppes, T, Bowden, CL, et al. A double-blind placebo-controlled, prophylaxis study of lamotrigine in rapid-cycling bipolar disorder. Lamictal 614 Study Group. J Clin Psychiatry. 2000;61:841–850.Google Scholar
6. Bowden, CL, Calabrese, JR, McElroy, SL, et al. The efficacy of lamotrigine in rapid cycling and non-rapid cycling patients with bipolar disorder. Biol Psychiatry. 1999;45:953–958.Google Scholar
7. Tohen, M, Chengappa, KN, Suppes, T, et al. Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy. Arch Gen Psychiatry. 2002;59:62–69.Google Scholar
8. Sachs, GS, Grossman, F, Ghaemi, SN, Okamoto, A, Bowden, CL. Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: a double-blind, placebo-controlled comparison of efficacy and safety. Am J Psychiatry. 2002;159:1146–1154.Google Scholar
9. Bowden, CL. Making optimal use of combination pharmacotherapy in bipolar disorder. J Clin Psychiatry. 2004;65(suppl 15):21–24.Google Scholar
10. Worrall, J, Moody, J, Peet, M, et al. Controlled studies of the acute antidepressant effects of lithium. Br J Psychiatry. 1979;135:255–262.Google Scholar
11. Bowden, CL, Collins, MA, McElroy, SL, et al. Relationship of mania symptomatology to maintenance treatment response with divalproex, lithium or placebo. Neuropsychopharmacology. 2005;30:1932–1939.Google Scholar
12. Bowden, CL, Calabrese, JR, McElroy, SL, et al. A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Arch Gen Psychiatry. 2000;57:481–489.Google Scholar
13. Goodwin, GM, Bowden, CL, Calabrese, JR, et al. A pooled analysis of 2 placebo-controlled 18-month trials of lamotrigine and lithium maintenance in bipolar I disorder. J Clin Psychiatry. 2004;65:432–441.Google Scholar
14. Bowden, C, Fawcett, J. Pharmacotherapy and risk of suicidal behaviors among patients with bipolar disorder. JAMA. 2004;291:939.Google Scholar